Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

Clinical trial NCT00235885 · COMPLETED

Trial details

NCT number: NCT00235885
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2005-07-01
Enrollment: 445

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.